China Biologic and Biosimilar Market will reach at a CAGR of 8.6% from to 2033
According to the Market Statsville Group (MSG), China Biologic and Biosimilar Market size was valued at USD 72,315.8 million in 2023, which is expected to grow from USD 88,128.3 million in 2024 to USD 137,729.0 million by 2033, at a CAGR of 8.6% during the forecast period (2024 to 2033). . Below information is analyzed in depth in the report-...
0 Comentários 0 Compartilhamentos 108 Visualizações 0 Anterior